The number of people living with reduced kidney function has more than doubled in the past three decades—from 378 million in ...

How to Run Faster was created with Runner’s World Training Plans in mind. They are designed for runners of all levels ...

Painkillers offer quick relief, but frequent misuse comes with hidden dangers. Doctors warn that in 2025, overuse quietly ...

Local and international experts warn that CKD patients are getting younger in recent years, primarily due to unhealthy lifestyle behaviors such as excessive consumption of processed foods that are ...

Technological advancement stagnates when met with bureaucratic sclerosis and corporate monopoly, according to this probing study from Oxford economic historian Frey (The Technology Trap). From early ...

Donald Trump has launched a $10 billion defamation lawsuit against the BBC, accusing the broadcaster of altering his words in a documentary about the Capitol riot. Cara Angeline Oliver has more.

To fast travel, you need to use Wevetseeds. Open your map, click on a World Tree, and expend a Wevetseed to travel to it. Needless to say, there are things that you might not know about the game, such ...

JEDEC is hammering out a CQDIMM standard for DDR5 CKD memory that will let future platforms cram in far higher capacities without slowing everything to a crawl. MSI and ADATA recently teamed up on an ...

Experts say we’re in a golden age for treating chronic kidney disease, with new drugs like Ozempic yielding major results. Will dialysis and organ transplants become a thing of the past? A healthy ...

On the first day of ASN 2025 Kidney Week, Dr Sumeska Thavarajah reports on several clinical trials in kidney disease that were presented, notably including a phase 2 study of rilparencel, a stem cell ...

The REMODEL study clarified which pathways are responsible for semaglutide’s cardiorenal effects in patients with CKD and type 2 diabetes. Glucagon-like peptide-1 receptor agonists (GLP1-RA) are a ...

Pove was generally safe and well tolerated with adverse events (AEs) that were mostly mild or moderate in severity. There were no serious adverse events related to povetacicept. The safety data is ...